Over a third of adults in the USA may be unknowingly using prescription medications that could increase the risk of depression and suicide.
ALKS 5461 accepted for review following previous refusal-to-file for depression: industry news round-up
In this week’s industry news round-up, we’ve chosen the latest updates from a wide range of disorders extending from depression to multiple sclerosis.
A new study has revealed that a nasal spray formulation of ketamine demonstrates promise in the rapid treatment of symptoms of major depression and suicidal thoughts.
In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more about our selection of the highlights this week.
Antidepressants are an effective treatment route for depression, novel study claims.
In this research article from Personalized Medicine, explore how disorders such as depression and schizophrenia have been linked to specific neurotransmitter receptor variations.
A new study implicates a novel gene target in the efficacy of electroconvulsive therapy as a depression treatment.
A new study sheds light on a genetic polymorphism that may play a role in major depressive disorder.
A recent study has suggested that physicians could determine whether a patient has major depression or bipolar disorder with a simple short electrocardiogram.
From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response
Discover the potential advantages of combining imaging and pharmacogenetics approaches in order to better describe the underlying mechanisms of antidepressant response and how this approach could be applied to future studies in this editorial from Pharmacogenomics.